Cellgorithmics
A genetic programming platform for the next generation of cellular biotechnologies.
- Stage Prototype Ready
- Industry Biotechnology
- Location Chicago, IL, USA
- Currency USD
- Founded 2019
- Employees 6
- Incorporation Type C-corp
- Website cellgorithm.com
Company Summary
Cellgorithmics has devised “Cellgorithms”, genetic algorithms (CRISPR/Cas9 based technology) that are inserted into cells to autonomously execute complex instructions. Cellgorithmics provides companies with diagnostic Cellgorithms to record events in their cell-manufacturing processes. These are used to design -tailored Cellgorithms, which are then manufactured by Cellgorithmics and delivered to companies for seamlessly integration.
Team
-
Genome editing, DNA repair, & Bioinformatics
MD/PhD Candidate
-
CEOCRISPR/Cas9 Biology, Genome Editing,& Synthetic Biology
-
Alex KreindlerCFOCorporate finance & development, business development
MBA
Partner, Kreindler Graf -
Dr. Brad Merrill, PhDCSOProfessor at University of Illinois at Chicago.
Experience in stem cell biology, genome editing, genomics.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.